Safety and Efficacy of CryoCor™ Cryoablation for PAF

NACompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Atrial Fibrillation
Interventions
DEVICE

Cardiac CryoCor Cryoablation System

Treatment with CryoCor Cardiac Cryoablation system

DRUG

Medical management

Medical management- treatment with standard medical therapy, which includes anti-arrhythmic medications

Trial Locations (24)

10025

St. Luke's-Roosevelt Hospital Center, New York

14642

University of Rochester Medical Center, Rochester

17033

Penn State Heart and Vascular Institute, Hershey

19102

Drexel University, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

27157

Wake Forest University Health Sciences, Winston-Salem

30308

Emory University, Atlanta

32611

University of Florida, Gainesville

33606

University of South Florida, Tampa

40504

Cardiology Associates of Kentucky, Lexington

50309

Iowa Heart Center, Des Moines

52803

Genesis Health, Davenport

53215

Heart Care Associates, Milwaukee

60637

University of Chicago Hospitals, Chicago

61801

Carle Heart Center, Urbana

68198

University of Nebraska Medical Center, Omaha

77030

Methodist Debakey Heart Center, Houston

78756

Austin Heart, PA, Austin

92103

UCSD Medical Center, San Diego

94143

UCSF Medical, San Francisco

95819

Regional Cardiology Associates, Sacramento

97239

Oregon Health and Science University, Portland

98415

Tacoma General, Tacoma

07631

Englewood Hospital and Medical Center, Englewood

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY